CB Health Ventures is a private equity firm and angel investment firm
CB Health Ventures is a private equity firm and angel investment firm. The firm was founded by Robert Schulz, in Boston, Massachusetts, United States.
The firm focuses on investing in opportunities in healthcare services, medical information technology, biotechnology, and genomics. The firm is interested in creating value for its portfolio companies. CB Health Ventures holds interest in companies that provide automated identification systems for pathogenic bacterial strains, medical and transplant devices, and protein and antibody products.
CB Health Ventures is a private equity firm and angel investment firm. The firm was founded by Robert SchulzRobert Schulz, in Boston, Massachusetts, United States.
The firm focuses on investing in opportunities in healthcare services, medical information technology, biotechnology, and genomics. The firm is interested increatingin creating value for its portfolio companies. CB Health Ventures holds interest in companies that provide automated identification systems for pathogenic bacterial strains, medical and transplant devices, and protein and antibody products.
CB Health Ventures is a private equity firm and angel investment firm. The firm was founded by Robert Schulz, in Boston, MassachusettsMassachusetts, United States.
CB Health Ventures is a private equity firmprivate equity firm and angel investment firm. The firm was founded by Robert Schulz, in Boston, Massachusetts, United States.
CB Health Ventures is a private equity firm and angel investment firm. The firm was founded by Robert Schulz, in BostonBoston, Massachusetts, United States.
CB Health Ventures is a private equity firm and angel investment firm
CB Health Ventures is a private equity firm and angel investment firm. The firm was founded by Robert Schulz, in Boston, Massachusetts, United States.
The firm focuses on investing in opportunities in healthcare services, medical information technology, biotechnology, and genomics. The firm is interested increating value for its portfolio companies.